Journal Articles
Clinical Breast Cancer
Year : 2008
Stéphane Delmotte : Connect in order to contact the contributor
https://hal.science/hal-00428276
Submitted on : Wednesday, October 28, 2009-5:24:10 PM
Last modification on : Thursday, July 20, 2023-2:25:22 PM
Cite
F. Descotes, B. Riche, S. Saez, G. de Laroche, J. Datchary, et al.. Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator. Clinical Breast Cancer, 2008, 8 (2), pp.168-177. ⟨10.3816/CBC.2008.n.018⟩. ⟨hal-00428276⟩
50
View
0
Download